(5) reported that a novel human monoclonal antibody (32A9), as a GPC-3-specifc antibody which efficiently eliminated GPC3-positive HCC cells in vitro and induced HCC xenograft tumor regressions in vivo. Here, GPC3 is linked to neoplasm.